ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy

Li, Xueyan; Zhong, Jiahui; Deng, Xue; Guo, Xuan; Lu, Yantong; Lin, Juze; Huang, Xuhui*; Wang, Changjun*广东省人民医院; 广州中医药大学; 南方医科大学
Frontiers in Immunology2021-12-22DOI: 10.3389/fimmu.2021.754196
13被引7阅读
引用收藏
分享

摘要

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that are activated under pathological conditions, such as cancer, or mature myeloid cells that are converted immune-suppressive cells via tumor-derived exosomes, and potently support the tumor processes at different levels. Currently, multiple studies have demonstrated that MDSCs induce immune checkpoint blockade (ICB) therapy resistance through their contribution to the immunosuppressive network in the tumor microenvironment. In addition, non-immunosuppressive mechanisms of MDSCs such as promotion of angiogenesis and induction of cancer stem cells also exert a powerful role in tumor progression. Thus, MDSCs are potential therapeutic targets to enhance the antitumor efficacy of ICB therapy in cases of multiple cancers. This review focuses on the tumor-promoting mechanism of MDSCs and provides an overview of current strategies that target MDSCs with the objective of enhancing the antitumor efficacy of ICB therapy.

学科与关键词

关键词
myeloid-derived suppressor cells (MDSCs)immune checkpoint blockade (ICB) therapyimmunosuppressionprogrammed cell death protein 1 (PD-1)the tumor microenvironment (TME)
相关
加载中…
  • Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
    Jin, Yuzhi; Huang, Yangyue; Ren, Hui; Huang, Huanhuan; Lai, Chunyu; Wang, Wenjun; Tong, Zhou; Zhang, Hangyu; Wu, Wei; Liu, Chuan; Bao, Xuanwen; Fang, Weijia; Li, Hongjun*; Zhao, Peng*; Dai, Xiaomeng*Biomaterials, 2024, 305: 122463.
  • Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells
    Lin, Shouheng; Zhang, Xuchao; Huang, Guohua; Cheng, Lin; Lv, Jiang; Zheng, Diwei; Lin, Simiao; Wang, Suna; Wu, Qiting; Long, Youguo; Li, Baiheng; Wei, Wei; Liu, Pentao; Pei, Duanqing; Li, Yangqiu; Wen, Zhesheng; Cui, Shuzhong; Li, Peng; Sun, Xiaofang*; Wu, Yilong*; Yao, Yao*Oncogene, 2021, 40(8): 1476-1489.被引 33
  • 髓系来源抑制细胞在肝癌微环境中作用研究进展
    岳元勋; 张跃伟Chinese Journal of Cancer Prevention and Treatment, 2019, (20): 1493-1498.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2021-12-22
卷期
第 12 卷
页码
754196
DOI
10.3389/fimmu.2021.754196
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation for Key Programs of China [81774261]; Project of Administration of Traditional Chinese Medicine of Guangdong Province of China [20191007]

作者

  • L

    Li, Xueyan (第一作者)

    southern med univ · guangdong prov peoples hosp

  • Z

    Zhong, Jiahui

    guangzhou univ chinese med

查看全部 8 位作者收起作者
  • D

    Deng, Xue

    southern med univ

  • G

    Guo, Xuan

  • L

    Lu, Yantong

    guangzhou univ chinese med

  • L

    Lin, Juze

    guangdong prov peoples hosp

  • H

    Huang, Xuhui (通讯)

    guangdong prov peoples hosp

  • W

    Wang, Changjun (通讯)

    southern med univ · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417